Aiphanol, a multi-targeting stilbenolignan, potently suppresses mouse lymphangiogenesis and lymphatic metastasis.

Abstract

The high incidence of lymphatic metastasis is closely related to poor prognosis and mortality in cancers. Potent inhibitors to prevent pathological lymphangiogenesis and lymphatic spread are urgently needed. The VEGF-C-VEGFR3 pathway plays a vital role in driving lymphangiogenesis and lymph node metastasis. In addition, COX2 in tumor cells and tumor-associated macrophages (TAMs) facilitates lymphangiogenesis. We recently reported that aiphanol, a natural stilbenolignan, attenuates tumor angiogenesis by repressing VEGFR2 and COX2. In this study, we evaluated the antilymphangiogenic and antimetastatic potency of aiphanol using in vitro, ex vivo and in vivo systems. We first demonstrated that aiphanol directly bound to VEGFR3 and blocked its kinase activity with an half-maximal inhibitory concentration (IC50) value of 0.29 μM in an in vitro ADP-GloTM kinase assay. Furthermore, we showed that aiphanol (7.5-30 μM) dose-dependently counteracted VEGF-C-induced proliferation, migration and tubular formation of lymphatic endothelial cells (LECs), which was further verified in vivo. VEGFR3 knockdown markedly mitigated the inhibitory potency of aiphanol on lymphangiogenesis. In 4T1-luc breast tumor-bearing mice, oral administration of aiphanol (5 and 30 mg· kg-1 ·d-1) dose-dependently decreased lymphatic metastasis and prolonged survival time, which was associated with impaired lymphangiogenesis, angiogenesis and, interestingly, macrophage infiltration. In addition, we found that aiphanol decreased the COX2-dependent secretion of PGE2 and VEGF-C from tumor cells and macrophages. These results demonstrate that aiphanol is an appealing agent for preventing lymphangiogenesis and lymphatic dissemination by synergistically targeting VEGFR3 and inhibiting the COX2-PGE2-VEGF-C signaling axis.

• Authors: Shan-Mei Chen, Chuan-Ke Zhao, Li-Cheng Yao, Li-Xin Wang, Yu-Nan Ma, Lin Meng, Shao-Qing Cai, Cai-Yun Liu, Li-Ke Qu, Yan-Xing Jia, Cheng-Chao Shou
• Journal: Acta pharmacologica Sinica (Acta Pharmacol Sin) Vol. 44 Issue 1 Pg. 189-200 (Jan 2023) ISSN: 1745-7254 [Electronic] United States
• PMID: 35778489 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Chemical References

• aiphanol
• Cyclooxygenase 2
• Dinoprostone
• Vascular Endothelial Growth Factor C
• Flt4 protein, mouse

Topics

• Animals
• Mice
• Cell Line, Tumor
• Cyclooxygenase 2 (metabolism)
• Dinoprostone (metabolism)
• Endothelial Cells (metabolism)
• Lymphangiogenesis
• Lymphatic Metastasis
• Vascular Endothelial Growth Factor C (metabolism)